202(top 1%)
PR articles
17.1K(top 1%)
PR citations
59(top 1%)
PR h-index
65(top 1%)
h-index
238
documents
21.2K
doc citations
3.3K
citing journals
100
times ranked

Publications

205 peer-reviewed articles • 18,399 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Severe acute liver disease in adults: Contemporary role of histopathology
Histopathology, 2024, 85, 549-561
3.611Citations (PDF)
2Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
Gut, 2022, 71, 382-390
16.8182Citations (PDF)
3The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis
Gastroenterology, 2022, 162, 890-906
0.9191Citations (PDF)
4COVID-19 and liver cancer: lost patients and larger tumours
BMJ Open Gastroenterology, 2022, 9, e000794
2.327Citations (PDF)
5The Balance of Stromal BMP Signaling Mediated by GREM1 and ISLR Drives Colorectal Carcinogenesis
Gastroenterology, 2021, 160, 1224-1239.e30
0.9147Citations (PDF)
6A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?
Cancers, 2021, 13, 1412
3.834Citations (PDF)
7The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study
BMC Gastroenterology, 2021, 21,
2.223Citations (PDF)
8Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
Journal of Hepatology, 2021, 75, 786-794
4.2180Citations (PDF)
9Drug-Induced Hepatocellular Injury Due to Herbal Supplement Ashwagandha
Journal of the Royal College of Physicians of Edinburgh, The, 2021, 51, 363-366
0.525Citations (PDF)
10Narrow-band imaging for scar (NBI-SCAR) classification: from conception to multicenter validation
Gastrointestinal Endoscopy, 2020, 91, 1146-1154.e5
1.812Citations (PDF)
11Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon
Journal of Gastroenterology and Hepatology (Australia), 2020, 35, 433-437
2.555Citations (PDF)
12The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease
Contemporary Clinical Trials, 2020, 98, 106175
1.6125Citations (PDF)
13Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease
American Journal of Gastroenterology, 2020, 115, 1289-1292
0.715Citations (PDF)
14A transcriptomic signature predicting fibrosis progression in a large European cohort of patients with histologically characterised NAFLD
Journal of Hepatology, 2020, 73, S109-S110
4.20Citations (PDF)
15Comparison of different virtual chromoendoscopy classification systems for the characterization of colorectal lesions
JGH Open, 2020, 4, 818-826
1.314Citations (PDF)
16Computer-aided diagnosis for characterization of colorectal lesions: comprehensive software that includes differentiation of serrated lesions
Gastrointestinal Endoscopy, 2020, 92, 891-899
1.848Citations (PDF)
17Learning curve for mastery of colorectal endoscopic submucosal dissection: Perspectives from a large Japanese cohort
JGH Open, 2020, 4, 611-616
1.313Citations (PDF)
18Deep learning uncertainty and confidence calibration for the five-class polyp classification from colonoscopy
Medical Image Analysis, 2020, 62, 101653
10.664Citations (PDF)
19Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆
Journal of Hepatology, 2020, 73, 505-515
4.2452Citations (PDF)
20Fifty years of impact on liver pathology: a history of the Gnomes
Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin, 2020, 478, 191-200
2.93Citations (PDF)
21Systems Genetics of Hepatic Metabolome Reveals Octopamine as a Target for Non-Alcoholic Fatty Liver Disease Treatment
Scientific Reports, 2019, 9,
3.414Citations (PDF)
22The degree of hepatic steatosis associates with impaired cardiac and autonomic function
Journal of Hepatology, 2019, 70, 1203-1213
4.267Citations (PDF)
23Cancer-associated fibroblasts in gastrointestinal cancer
Nature Reviews Gastroenterology and Hepatology, 2019, 16, 282-295
45.8532Citations (PDF)
24Effect of time of day and specialty on polyp detection rates in Australia
Journal of Gastroenterology and Hepatology (Australia), 2019, 34, 899-906
2.517Citations (PDF)
25Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)
Histopathology, 2018, 73, 369-385
3.648Citations (PDF)
26Cellular senescence drives age-dependent hepatic steatosis
Nature Communications, 2017, 8,
13.7984Citations (PDF)
27Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity
Nature, 2017, 551, 340-345
37.9563Citations (PDF)
28Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial
Clinical Gastroenterology and Hepatology, 2017, 15, 96-102.e3
6.0199Citations (PDF)
29Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis
American Journal of Gastroenterology, 2017, 112, 740-751
0.7826Citations (PDF)
30A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
PLoS ONE, 2017, 12, e0175717
2.352Citations (PDF)
31Columnar Metaplasia in the Esophageal Remnant After Esophagectomy
Annals of Surgery, 2016, 264, 1016-1021
4.614Citations (PDF)
32Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma
British Journal of Cancer, 2016, 115, 797-804
5.520Citations (PDF)
33Elevated transaminase levels among overweight adolescents in eastern China
Acta Paediatrica, International Journal of Paediatrics, 2016, 105,
1.61Citations (PDF)
34DNA-PK—A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival
Clinical Cancer Research, 2015, 21, 925-933
6.882Citations (PDF)
35Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
Journal of Hepatology, 2015, 62, 1148-1155
4.2994Citations (PDF)
36Diagnosis and Assessment of NAFLD: Definitions and Histopathological Classification
Seminars in Liver Disease, 2015, 35, 207-220
3.1134Citations (PDF)
37Serum immunoglobulin levels predict fibrosis in patients with non-alcoholic fatty liver disease
Journal of Hepatology, 2014, 60, 1055-1062
4.2113Citations (PDF)
38Pathology of the liver sinusoids
Histopathology, 2014, 64, 907-920
3.674Citations (PDF)
39Clinical but not histological factors predict long‐term prognosis in patients with histologically advanced non‐decompensated alcoholic liver disease
Liver International, 2014, 34, 235-242
3.940Citations (PDF)
40A reversible model for periportal fibrosis and a refined alternative to bile duct ligation
Toxicology Research, 2014, 3, 98-109
2.111Citations (PDF)
41TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease
Nature Communications, 2014, 5,
13.7574Citations (PDF)
42Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
Journal of Hepatology, 2014, 61, 75-81
4.2529Citations (PDF)
43White cell count and platelet count associate with histological alcoholic hepatitis in jaundiced harmful drinkers
BMC Gastroenterology, 2013, 13,
2.231Citations (PDF)
44520 TRANSPLANTATION FOR ALD: LESSONS FROM THE EXPLANT
Journal of Hepatology, 2013, 58, S213
4.20Citations (PDF)
45Adult human exocrine pancreas differentiation to hepatocytes – potential source of a human hepatocyte progenitor for use in toxicology research
Toxicology Research, 2013, 2, 80-87
2.110Citations (PDF)
46Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
Hepatology, 2013, 57, 103-111
10.1111Citations (PDF)
4774 APPLICATION, UTILITY AND VALIDATION OF A NEW HISTOLOGICAL SYSTEM FOR CLASSIFICATION OF NAFLD IN PATIENTS WITH METABOLIC SYNDROME
Journal of Hepatology, 2013, 58, S33
4.20Citations (PDF)
48Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model
Journal of Hepatology, 2013, 59, 318-326
4.2108Citations (PDF)
49Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser
Journal of Clinical Virology, 2013, 58, 331-333
3.017Citations (PDF)
501368 FURTHER VALIDATION OF TERMINAL PEPTIDE OF PROCOLLAGEN III (PIIINP) FOR THE DETECTION AND ASSESSMENT OF NONALCOHOLIC STEATOHEPATITIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
Journal of Hepatology, 2013, 58, S550
4.20Citations (PDF)
511275 CARRIAGE OF PNPLA3 I148M IS ASSOCIATED WITH AN INCREASED RISK OF NON-ALCOHOLIC FATTY LIVER DIESEASE ASSOCIATED HEPATOCELLULAR CARCINOMA
Journal of Hepatology, 2013, 58, S516
4.27Citations (PDF)
52Development of a robust protocol for gene expression analysis using formalin-fixed, paraffin-embedded liver transplant biopsy specimens
Journal of Clinical Pathology, 2013, 66, 815-818
1.72Citations (PDF)
53Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?
European Journal of Gastroenterology and Hepatology, 2013, 25, 652-658
1.385Citations (PDF)
54Inhibition of RelA-Ser536 Phosphorylation by a Competing Peptide Reduces Mouse Liver Fibrosis Without Blocking the Innate Immune Response
Hepatology, 2013, 57, 817-828
10.142Citations (PDF)
55Cholestase bei jungen Männern nach Anabolika-Einnahme
Praxis, 2012, 101, 661-664
0.20Citations (PDF)
56Cholestasis secondary to anabolic steroid use in young men
BMJ: British Medical Journal, 2012, 344, e468-e468
0.131Citations (PDF)
57Multigenerational epigenetic adaptation of the hepatic wound-healing response
Nature Medicine, 2012, 18, 1369-1377
33.0271Citations (PDF)
58Chemotherapy-Associated Liver Injury in Patients with Colorectal Liver Metastases: A Systematic Review and Meta-analysis
Annals of Surgical Oncology, 2012, 19, 4287-4299
2.3207Citations (PDF)
59Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease
Hepatology, 2012, 55, 1083-1093
10.162Citations (PDF)
60Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation
Hepatology, 2012, 56, 1129-1139
10.1126Citations (PDF)
61Liver cell dysplasia and early hepatocellular carcinoma
Diagnostic Histopathology, 2011, 17, 512-520
0.40Citations (PDF)
62Lymph Node Metastasis in Early Esophageal Adenocarcinoma
Annals of Surgery, 2011, 254, 731-737
4.661Citations (PDF)
63Stimulating healthy tissue regeneration by targeting the 5-HT2B receptor in chronic liver disease
Nature Medicine, 2011, 17, 1668-1673
33.0207Citations (PDF)
64ORTHOTOPIC LIVER TRANSPLANTATION: CORRELATION BETWEEN STRESS-INDUCED SENESCENCE AND EPITHELIAL TO MESENCHYMAL TRANSITION OF THE BILIARY EPITHELIUM?
Transplantation, 2010, 90, 493
2.10Citations (PDF)
65the C-Rel Subunit of Nuclear Factor-κB Regulates Murine Liver Inflammation, Wound-Healing, and Hepatocyte Proliferation
Hepatology, 2010, 51, 922-931
10.157Citations (PDF)
66T Cell-mediated biliary epithelial-to-mesenchymal transition in liver allograft rejection
Liver Transplantation, 2010, 16, 567-576
2.511Citations (PDF)
67Elevated endotoxin levels in non-alcoholic fatty liver disease
Journal of Inflammation, 2010, 7, 15
4.0350Citations (PDF)
68Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
Gut, 2010, 59, 1245-1251
16.8301Citations (PDF)
69Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease
Gut, 2010, 59, 1265-1269
16.8838Citations (PDF)
70Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
Gut, 2010, 59, 267-273
16.8167Citations (PDF)
71Results of a Two-Center Study Comparing Hepatic Fibrosis Progression in HCV-positive Liver Transplant Patients Receiving Cyclosporine or Tacrolimus
Transplantation Proceedings, 2010, 42, 4573-4577
0.79Citations (PDF)
72Disrupted Pancreatic Exocrine Differentiation and Malabsorption in Response to Chronic Elevated Systemic Glucocorticoid
American Journal of Pathology, 2010, 177, 1225-1232
3.420Citations (PDF)
73704 IDENTIFICATION OF CANDIDATE GENES IN DIET INDUCED NON-ALCOHOLIC FATTY LIVER DISEASE IN INBRED MICE
Journal of Hepatology, 2009, 50, S258
4.20Citations (PDF)
741001 CYTOCHOME P450 2E1 (CYP2E1) AUTOREACTIVITY IN ALCOHOLIC LIVER DISEASE: NO EVIDENCE FOR A PATHOGENETIC ROLE
Journal of Hepatology, 2009, 50, S363
4.20Citations (PDF)
75Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers
Hepatology, 2008, 47, 455-460
10.1675Citations (PDF)
76Ontogeny of human intrahepatic innervation
Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin, 2008, 452, 435-442
2.913Citations (PDF)
77Epithelial to mesenchymal transition in primary sclerosing cholangitis
Liver International, 2008, 28, 1176-1177
3.96Citations (PDF)
78Mutations in CHD7 in patients with CHARGE syndrome cause T–B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome
Clinical and Experimental Immunology, 2008, 153, 75-80
3.3117Citations (PDF)
79Fibrosis and Cirrhosis Reversibility – Molecular Mechanisms
Clinics in Liver Disease, 2008, 12, 915-937
3.578Citations (PDF)
80Liver fibrosis
Biochemical Journal, 2008, 411, 1-18
3.8287Citations (PDF)
81Fatigue in non-alcoholic fatty liver disease (NAFLD) is significant and associates with inactivity and excessive daytime sleepiness but not with liver disease severity or insulin resistance
Gut, 2008, 57, 807-813
16.8189Citations (PDF)
82The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD
Hepatology, 2007, 45, 846-854
10.12,942Citations (PDF)
83Biliary epithelial-mesenchymal transition in posttransplantation recurrence of primary biliary cirrhosis
Hepatology, 2007, 45, 977-981
10.1150Citations (PDF)
84Pathology of liver tumours
Surgery, 2007, 25, 10-15
0.32Citations (PDF)
85The diffuse stellate cell system
Journal of Molecular Histology, 2007, 38, 53-64
2.075Citations (PDF)
86Epithelial–mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease
Laboratory Investigation, 2007, 88, 112-123
3.2221Citations (PDF)
87Alcoholic liver disease
Seminars in Diagnostic Pathology, 2006, 23, 149-160
2.7148Citations (PDF)
88Late Humoral Rejection in a Compliant ABO-compatible Liver Transplant Recipient
Transplantation, 2006, 82, 988-989
2.138Citations (PDF)
89Chronic Allograft Nephropathy: Intraepithelial Signals Generated by Transforming Growth Factor-β and Bone Morphogenetic Protein-7
American Journal of Transplantation, 2006, 6, 1367-1376
4.541Citations (PDF)
90Phospholipase D and extracellular signal-regulated kinase in hepatic stellate cells: effects of platelet-derived growth factor and extracellular nucleotides
American Journal of Physiology - Renal Physiology, 2006, 291, G977-G986
3.211Citations (PDF)
91Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation
Journal of Clinical Pathology, 2006, 59, 174-178
1.716Citations (PDF)
92Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients
Journal of Virology, 2006, 80, 2418-2428
3.6313Citations (PDF)
93Mast cells and c-Kit expression in liver allograft rejection
Histopathology, 2005, 47, 375-381
3.623Citations (PDF)
94A liver fibrosis cocktail? Psoriasis, methotrexate and genetic hemochromatosis
BMC Dermatology, 2005, 5,
2.53Citations (PDF)
95Study of Apoptosis and Heat Shock Protein (HSP) Expression in Hepatocytes Following Radiofrequency Ablation (RFA)
Journal of Surgical Research, 2005, 129, 147-151
1.675Citations (PDF)
96Chronic Renal Allograft Dysfunction
Journal of the American Society of Nephrology: JASN, 2004, 15, 390-397
0.4116Citations (PDF)
97Spectrum of liver pathology in immune mediated liver diseases
Journal of Gastroenterology and Hepatology (Australia), 2004, 19, S353-S355
2.51Citations (PDF)
98Monitoring methotrexate‐induced hepatic fibrosis in patients with psoriasis: are serial liver biopsies justified?
Alimentary Pharmacology and Therapeutics, 2004, 19, 391-399
3.7111Citations (PDF)
99Sentinel node biopsy to evaluate the metastatic dissemination of oesophageal adenocarcinoma
British Journal of Surgery, 2004, 92, 60-67
0.373Citations (PDF)
100Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse
Hepatology, 2004, 39, 1583-1592
10.128Citations (PDF)
101Serum markers detect the presence of liver fibrosis: A cohort study
Gastroenterology, 2004, 127, 1704-1713
0.91,045Citations (PDF)
102The sentinel node concept in the metastatic dissemination of esophageal adenocarcinoma
Gastroenterology, 2003, 124, A104
0.90Citations (PDF)
103Metastatic breast carcinoma presenting as acute liver failure and portal hypertension
American Journal of Gastroenterology, 2002, 97, 750-751
0.717Citations (PDF)
104Familial primary biliary cirrhosis and autoimmune cholangitis
Digestive and Liver Disease, 2002, 34, 50-52
2.56Citations (PDF)
105Primary biliary cirrhosis and other ductopenic diseases
Clinics in Liver Disease, 2002, 6, 363-380
3.538Citations (PDF)
106Investigation of a Mechanism for Accelerated Breakdown of Immune Tolerance to the Primary Biliary Cirrhosis–Associated Autoantigen, Pyruvate Dehydrogenase Complex
Laboratory Investigation, 2002, 82, 211-219
3.229Citations (PDF)
107Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex
Hepatology, 2002, 36, 679-686
10.148Citations (PDF)
108Metastatic breast carcinoma presenting as acute liver failure and portal hypertension
American Journal of Gastroenterology, 2002, 97, 750-751
0.70Citations (PDF)
109Relationship between TGFβ1, intratubular CD103 positive T cells and acute renal allograft rejection
Transplantation Proceedings, 2001, 33, 1159
0.76Citations (PDF)
110TGF-β expression in protocol transplant liver biopsies: a comparative study between cyclosporine-A (CyA) and tacrolimus (FK 506) immunosuppression
Transplantation Proceedings, 2001, 33, 1378-1380
0.77Citations (PDF)
111TUBULITIS AFTER RENAL TRANSPLANTATION: DEMONSTRATION OF AN ASSOCIATION BETWEEN CD103+ T CELLS, TRANSFORMING GROWTH FACTOR ??1 EXPRESSION AND REJECTION GRADE 1
Transplantation, 2001, 71, 306-313
2.163Citations (PDF)
112Managing chronic hepatitis C acquired through intravenous drug use
QJM - Monthly Journal of the Association of Physicians, 2001, 94, 153-158
0.545Citations (PDF)
113Overexpression of HER2/neu in solid tumours: an immunohistochemical survey
Histopathology, 2001, 38, 96-104
3.6146Citations (PDF)
114The role of phosphatidic acid in platelet-derived growth factor-induced proliferation of rat hepatic stellate cells
Hepatology, 2000, 31, 95-100
10.126Citations (PDF)
115Experimental autoimmune cholangitis: a mouse model of immune-mediated cholangiopathy
Liver International, 2000, 20, 351-356
3.934Citations (PDF)
116Presentation and mortality of primary biliary cirrhosis in older patients
Age and Ageing, 2000, 29, 305-309
1.826Citations (PDF)
117Ulcerative colitis: An investigation of the potential role played by AEB7 +ve T-cells
Gastroenterology, 2000, 118, A1334
0.90Citations (PDF)
118Stress-activated protein kinases in the activation of rat hepatic stellate cells in culture
Journal of Hepatology, 2000, 32, 465-472
4.274Citations (PDF)
119Pathology of Viral Hepatitis
Histopathology, 1999, 35, 179-179
3.60Citations (PDF)
120Pathobiology of hepatic stellate cells
Journal of Gastroenterology, 1999, 34, 299-304
4.151Citations (PDF)
121Composition of the Pulmonary Interstitium during Normal Development of the Human Fetus
Pediatric and Developmental Pathology, 1999, 2, 424-431
1.119Citations (PDF)
122Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol
Journal of Immunological Methods, 1999, 223, 93-106
1.419Citations (PDF)
123Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis
Hepatology, 1999, 30, 53-57
10.1103Citations (PDF)
124Primary biliary cirrhosis once rare, now common in the United Kingdom?
Hepatology, 1999, 30, 390-394
10.1218Citations (PDF)
125Macrophage and hepatic stellate cell responses during experimental hepatocarcinogenesis
Journal of Gastroenterology and Hepatology (Australia), 1998, 13, 145-151
2.516Citations (PDF)
126Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C
Hepatology, 1998, 27, 1695-1699
10.1209Citations (PDF)
127Anti-hepatocyte growth factor antibody inhibits hepatocyte proliferation during liver regeneration
Journal of Pathology, 1998, 185, 298-302
4.960Citations (PDF)
128Hepatitis G virus does not cause significant liver disease after liver transplantation
Journal of Viral Hepatitis, 1998, 5, 35-42
1.915Citations (PDF)
129Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia Major
New England Journal of Medicine, 1998, 339, 417-423
34.5399Citations (PDF)
130Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease
Gut, 1998, 43, 262-266
16.888Citations (PDF)
131Colonic epithelial cell proliferation in hereditary non-polyposis colorectal cancer
Gut, 1998, 43, 85-92
16.826Citations (PDF)
132Outcome of post-transfusion hepatitis C: disease severity in blood- component recipients and their implicated donors
QJM - Monthly Journal of the Association of Physicians, 1997, 90, 587-592
0.515Citations (PDF)
133Autoimmune hepatitis in older patients
Age and Ageing, 1997, 26, 441-444
1.861Citations (PDF)
134Characterisation of the DNA repair enzyme for O6-methylguanine in cirrhosis
Journal of Hepatology, 1996, 25, 158-165
4.216Citations (PDF)
135Intra-observer variation in the histopathological assessment of chronic viral hepatitis
Journal of Hepatology, 1996, 25, 649-654
4.2160Citations (PDF)
136Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis
Journal of Hepatology, 1996, 25, 677-683
4.2142Citations (PDF)
137Cushing's syndrome secondary to ectopic ACTH secretion from a primary ovarian carcinoma
Clinical Endocrinology, 1996, 45, 775-778
2.314Citations (PDF)
138Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis
Hepatology, 1996, 24, 1282-1287
10.119Citations (PDF)
139Hepatic allograft rejection: Regulation of the immunogenicity of human intrahepatic biliary epithelial cells
Liver Transplantation, 1996, 2, 37-45
3.013Citations (PDF)
140CD44 IS EXPRESSED IN HEPATOCELLULAR CARCINOMAS SHOWING VASCULAR INVASION
1996, 179, 74-79
57Citations (PDF)
141TRANSFORMING GROWTH FACTOR-α EXPRESSION IS ALTERED DURING EXPERIMENTAL HEPATOCARCINOGENESIS
1996, 179, 276-282
21Citations (PDF)
142Hepatitis C virus: epidemiology and genotypes in the north east of England.
Gut, 1996, 38, 269-276
16.862Citations (PDF)
143Non-Hodgkin's Lymphoma and Hepatitis C Virus Infection
Leukemia and Lymphoma, 1996, 21, 127-130
1.463Citations (PDF)
144Cellular distribution of androgen receptors in the liver.
Journal of Clinical Pathology, 1996, 49, 418-420
1.716Citations (PDF)
145Innervation of the liver: morphology and function
Liver, 1996, 16, 151-160
0.061Citations (PDF)
146Intrahepatic mast cells in chronic liver diseases
Hepatology, 1995, 22, 1175-1181
10.193Citations (PDF)
147The natural history of nonalcoholic fatty liver: A follow-up study
Hepatology, 1995, 22, 1714-1719
10.1877Citations (PDF)
148Methylprednisolone does not inhibit the nonparenchymal cell responses to dimethylnitrosamine-induced liver injury
International Hepatology Communications, 1995, 4, 201-206
0.50Citations (PDF)
149Immunogenicity of biliary epithelial cells: study of the expression of B7 molecules
Journal of Hepatology, 1995, 22, 591-595
4.250Citations (PDF)
150Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver
Lancet, The, 1995, 346, 987-990
62.1471Citations (PDF)
151Intrahepatic mast cells in chronic liver diseases*1
Hepatology, 1995, 22, 1175-1181
10.1107Citations (PDF)
152The natural history of nonalcoholic fatty liver: A follow-up study
Hepatology, 1995, 22, 1714-1719
10.181Citations (PDF)
153Post-infantile giant cell hepatitis: histological and immunohistochemical study.
Journal of Clinical Pathology, 1994, 47, 1022-1027
1.752Citations (PDF)
154Expression of mutant p53 protein in hepatocellular carcinoma.
Gut, 1994, 35, 98-100
16.820Citations (PDF)
155Quantitative analysis of macrophages and perisinusoidal cells in primary biliary cirrhosis
Histopathology, 1994, 25, 65-70
3.635Citations (PDF)
156Non-parenchymal cell responses in paracetamol (acetaminophen)-induced liver injury
Journal of Hepatology, 1994, 20, 537-541
4.233Citations (PDF)
157A two year controlled trial examining the effectiveness of ursodeoxycholic acid in primary biliary cirrhosis
Journal of Gastroenterology and Hepatology (Australia), 1994, 9, 162-168
2.546Citations (PDF)
158Intrahepatic distribution of transforming growth factor-alpha (TGFα) during liver regeneration following carbon tetrachlorideinduced necrosis
Journal of Pathology, 1993, 170, 95-100
4.946Citations (PDF)
159Cellular and molecular aspects of hepatic fibrosis
Journal of Pathology, 1993, 170, 105-114
4.9130Citations (PDF)
160Bile duct proliferation?its true significance?
Histopathology, 1993, 23, 599-602
3.650Citations (PDF)
161Pathology of alcoholic liver disease
Bailliere's Clinical Gastroenterology, 1993, 7, 641-662
1.412Citations (PDF)
162Morphologic Investigation of Sinusoidal Cells
Seminars in Liver Disease, 1993, 13, 21-38
3.158Citations (PDF)
163Plasma Membrane Form of Phosphatidate Phosphohydrolase: A Possible Role in Signal Transduction during Liver Fibrogenesis
Clinical Science, 1993, 85, 281-287
6.27Citations (PDF)
164Expression of transforming growth factor alpha in human hepatocellular carcinoma
Liver, 1993, 13, 151-155
0.028Citations (PDF)
165CD30 expression by peripheral blood monocytes and hepatic macrophages in a child with miliary tuberculosis.
Journal of Clinical Pathology, 1992, 45, 638-639
1.79Citations (PDF)
166Disappearance of hepatic parenchymal nerves in human liver cirrhosis.
Gut, 1992, 33, 87-91
16.847Citations (PDF)
167Glutathione S-transferases in neonatal liver disease.
Journal of Clinical Pathology, 1992, 45, 679-683
1.717Citations (PDF)
168c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma
Journal of Hepatology, 1992, 14, 377-380
4.255Citations (PDF)
169Liver fibrosis.
BMJ: British Medical Journal, 1992, 305, 537-538
0.17Citations (PDF)
170Macrophage and perisinusoidal cell kinetics in acute liver injury
Journal of Pathology, 1992, 166, 351-358
4.9119Citations (PDF)
171Hepatic reinnervation following orthotopic liver transplantation in man
Journal of Pathology, 1992, 167, 217-222
4.941Citations (PDF)
172Immunolocalization of proliferating perisinusoidal cells in rat liver
The Histochemical Journal, 1992, 24, 67-72
0.223Citations (PDF)
173Light microscopic and ultrastructural distribution of type VI collagen in human liver: alterations in chronic biliary disease
Histopathology, 1992, 21, 335-344
3.631Citations (PDF)
174Nodular regenerative hyperplasia of the liver in Behçet's disease
Histopathology, 1992, 20, 452-454
3.610Citations (PDF)
175Fibrin-ring granulomas: a non-specific reaction to liver injury?
Histopathology, 1991, 19, 91-93
3.627Citations (PDF)
176Basement membrane proteins in the space of Disse: a reappraisal.
Journal of Clinical Pathology, 1991, 44, 646-648
1.729Citations (PDF)
177Abnormalities of intrahepatic bile ducts in extrahepatic biliary atresia
Histopathology, 1990, 17, 521-527
3.679Citations (PDF)
178Ultrastructural localization of extracellular matrix proteins in liver biopsies using ultracryomicrotomy and immuno-gold labelling
Histopathology, 1990, 16, 53-58
3.640Citations (PDF)
179An abstract machine for the implementation of PARLOG on uniprocessors
New Generation Computing, 1989, 6, 389-420
2.314Citations (PDF)
180Localization of adrenergic and neuropeptide tyrosine-containing nerves in the mammalian liver
Hepatology, 1989, 9, 839-845
10.163Citations (PDF)
181Intrasplenic hepatocyte transplantation in rats with experimental liver injury: Morphological and morphometric studies
Journal of Pathology, 1989, 159, 67-73
4.934Citations (PDF)
182In vitro differentiation of fat-storing cells parallels marked increase of collagen synthesis and secretion
Journal of Hepatology, 1989, 9, 59-68
4.2182Citations (PDF)
183Letters to the editor
Journal of Pathology, 1988, 154, 287-288
4.91Citations (PDF)
184Unusual variant of primary sclerosing cholangitis.
Journal of Clinical Pathology, 1987, 40, 541-545
1.78Citations (PDF)
185Expression of tissue polypeptide antigen (TPA) in fetal and adult liver: changes in liver disease.
Journal of Clinical Pathology, 1987, 40, 719-724
1.724Citations (PDF)
186Mixed Follicular-Parafollicular Carcinoma of the Thyroid
Scottish Medical Journal, 1987, 32, 50-51
1.29Citations (PDF)
187Dermoid Cyst of the Testis
Scottish Medical Journal, 1987, 32, 146-148
1.212Citations (PDF)
188NEUROPEPTIDE Y IN MULTIPLE ENDOCRINE NEOPLASIA: RELEASE DURING SURGERY FOR PHAEOCHROMOCYTOMA
Clinical Endocrinology, 1987, 26, 75-84
2.314Citations (PDF)
189Prognostic factors in thyroid tumours
British Journal of Cancer, 1986, 54, 475-482
5.543Citations (PDF)
190Desmin-containing stellate cells in rat liver; distribution in normal animals and response to experimental acute liver injury
Journal of Pathology, 1986, 150, 29-35
4.9124Citations (PDF)
191Histologic Spectrum of Alcoholic Liver Disease
Seminars in Liver Disease, 1986, 6, 221-232
3.1255Citations (PDF)
192Fine needle aspiration cytology: experience with a cell block technique.
Journal of Clinical Pathology, 1986, 39, 114-115
1.719Citations (PDF)
193The effect of 5-fluorouracil on rat adrenal function
Medical Oncology and Tumor Pharmacotherapy, 1986, 3,
1.41Citations (PDF)
194Breast cancer in women with primary biliary cirrhosis.
BMJ: British Medical Journal, 1985, 291, 1597-1598
0.164Citations (PDF)
195Lymphoid and epithelial markers in small cell anaplastic thyroid tumours.
Journal of Clinical Pathology, 1985, 38, 893-896
1.720Citations (PDF)
196The cellular pathology of primary biliary cirrhosis
Molecular Aspects of Medicine, 1985, 8, 269-291
9.421Citations (PDF)
197Acquired immunodeficiency syndrome in a patient with no known risk factors: a pathological study.
Journal of Clinical Pathology, 1984, 37, 471-474
1.720Citations (PDF)
198Thyroglobulin in carcinoma of the thyroid
Human Pathology, 1984, 15, 197-198
2.34Citations (PDF)
199Pyrexia of undetermined origin, diarrhoea, and primary cerebral lymphoma associated with acquired immunodeficiency.
BMJ: British Medical Journal, 1984, 288, 449-450
0.110Citations (PDF)
200Liver membrane antibodies in alcoholic liver disease: 1. prevalence and immunoglobulin class.
Gut, 1982, 23, 221-225
16.845Citations (PDF)
201Diagnosis of primary thyroid carcinoma by immunohistological demonstration of thyroglobulin
Histopathology, 1979, 3, 279-286
3.676Citations (PDF)
202Rise in Female-Initiated Sexual Activity at Ovulation and Its Suppression by Oral Contraceptives
New England Journal of Medicine, 1978, 299, 1145-1150
34.5216Citations (PDF)
203Title is missing!
0
1Citations (PDF)
204Investigating the mechanisms of indocyanine green tumour uptake in sarcoma cell lines and ex vivo human tissue
Journal of Pathology, 0, 267, 315-328
4.95Citations (PDF)
205Head to head: should portal inflammation be part of grading necroinflammatory activity in metabolic dysfunction‐associated steatotic liver disease?
Histopathology, 0, 88, 958-969
3.61Citations (PDF)